Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.

@article{Samaras2011ValidationOP,
  title={Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.},
  author={Panagiotis Samaras and Marcel Blickenstorfer and Sarah Roberta Haile and Raffaele Daniele Siciliano and Ulf Petrausch and Axel Mischo and Martin Zweifel and Hanspeter Honegger and Urs Schanz and Georg Stussi and Christian J Taverna and Stefan Bauer and Alexander K. Knuth and Frank Stenner-Liewen and Christoph Renner},
  journal={Swiss medical weekly},
  year={2011},
  volume={141},
  pages={
          w13203
        }
}
PRINCIPLES High-dose chemotherapy with subsequent autologous stem cell transplantation (ASCT) is an important treatment option in younger patients with multiple myeloma (MM). We analysed the outcome of patients treated at our institution outside the clinical trials framework and tried to identify risk factors prognostic for survival. METHODS Medical histories of the patients were screened for response, event-free survival (EFS) and overall survival (OS). Pre-transplant variables were analysed… CONTINUE READING
4 Citations
35 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Similar Papers

Loading similar papers…